Search in:

OncoTargets and Therapy Volume 8, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

Jing WangDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China

Min ZhouDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China

Jing-Yan XuDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China

Bing ChenDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]

Jian OuyangDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People’s Republic of China

Pages 2645-2650 | Published online: 18 Sep 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (9)

Yildiz IPEK & Güven YILMAZ. (2023) Factors associated with unresponsiveness to treatment in patients with non-Hodgkin lymphoma: 10 years of experience from a single centerNon-Hodgkin lenfoma hastalarında tedaviye yanıtsızlık ile ilişkili faktörler: Tek merkezden 10 yıllık deneyim. Acta Medica Alanya 7:1, pages 66-80.
Crossref

Shunrong Sun, Wulipan Fulati, Lin Shen, Min Wu, Zilan Huang, Wensi Qian, Pingping Chen, Yingwei Hu, Mingyue Chen, Yu Xu, Hongdi Zhang, Jiexian Ma & Yanhui Xie. (2023) Maintenance regimen of GM‐CSF with rituximab and lenalidomide improves survival in high‐risk B‐cell lymphoma by modulating natural killer cells . Cancer Medicine 12:12, pages 12975-12985.
Crossref

Sufeng Zhao, Li An, Xudong Yang, Zheng Wei, He Zhang & Yufeng Wang. (2022) Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma. Frontiers in Oncology 12.
Crossref

Jisun Hwang, Chong Suh, Kyung Kim, Ho Kim, Austin Kim, Jeffrey Craig, Ke Chen, Joel Roberson, Jeffrey Guenette & Raymond Huang. (2021) The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Cancers 13:13, pages 3369.
Crossref

Wenqin Yue, Bin Liu, Lei Gao, Miaoxia He, Jianmin Wang, Weiping Zhang, Li Chen, Xiaoxia Hu, Lili Xu & Jianmin Yang. (2018) The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma. Clinica Chimica Acta 485, pages 316-322.
Crossref

Seok-Hyun Kim, Se-Il Go, Jangho Seo, Myoung Hee Kang, Sung Woo Park, Hoon-Gu Kim & Gyeong-Won Lee. (2018) Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP. Leukemia Research 71, pages 100-105.
Crossref

Thomas Menter, Hanine Medani, Raida Ahmad, Rashpal Flora, Pritesh Trivedi, Alistair Reid & Kikkeri N. Naresh. (2016) MYC and BCL 2 evaluation in routine diagnostics of aggressive B‐cell lymphomas – presentation of a work‐flow and the experience with 248 cases . British Journal of Haematology 179:4, pages 681-684.
Crossref

Jing Wang, Min Zhou, Xiaoyue Wang, Jingyan Xu, Bing Chen & Jian Ouyang. (2016) Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP. Clinica Chimica Acta 459, pages 150-154.
Crossref

Penelope Korkolopoulou, Theodoros Vassilakopoulos, Vassilios Milionis & Maria Ioannou. (2016) Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Advances in Anatomic Pathology 23:4, pages 202-243.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date